Champions Oncology (CSBR) Market Capitalization

Graphic logo of Champions Oncology (CSBR)

The price visualization on GURU.Markets for Champions Oncology (CSBR), where the market capitalization is 0.07, assists in the basic asset valuation and demonstrates the company's leadership in creating IT platforms for drug testing on living tissues with a unique biobank. The business implements a personalized approach by creating laboratory replicas of neoplasms to select the appropriate therapy. Operational stability is guaranteed by a streamlined global express transport system for biomaterials with strict temperature control.

CSBR Champions Oncology, Inc.: Market Value in the range 07/04/2022 - 11/16/2026

Metric breakdowns and analytics for Champions Oncology Inc (CSBR)

- market price and analyst price targets:
Fundamental company valuation:Champions Oncology, Inc. CSBR
Product sample of Champions Oncology, Inc.

Market capitalization aggregates the value of all outstanding shares, determining the overall scale of the business within a fundamental valuation. The dynamics of this metric allow investors to filter out volatility, revealing the real trend in asset value. Analyzing the company's market value helps align the current development phase with historical cycles. For Champions Oncology (CSBR), this indicator reflects market confidence in personalized PDX models. The business value grows through the synergy of strategic partnerships with biotech laboratories.

Competitors of Champions Oncology (CSBR)

Market Value BeiGene Ltd ONC|Market Capitalization Halozyme Corp HALO|RVMD - Market Value|Market Valuation AAPG|CG Oncology Corp (CGON) - Market Value|Market Capitalization URGN|BCAX (Bicara Corp) - Market Capitalization|Market Valuation Personalis Corp (PSNL)|Market Capitalization ERAS|Market Capitalization delcath.com (DCTH)|Market Value YmAbs YMAB|AURA: Market Capitalization|Candel Therapeutics, Inc. - Market Capitalization|Accuray Inc. (ARAY) - Market Valuation|SELLAS Life Sciences Group Inc. (SLS) - Market Value|Market Value actuatetherapeutics.com (ACTU)|Market Value Citius Oncology|HURA: Market Value|Market Valuation TARA (Protara)|FATE (Fate Therapeutics Corp) - Market Value|Market Capitalization WHWK (Aadi Bioscience Inc)|TCRX - Market Valuation|XBIT: Market Valuation|Market Value CVM (cel-sci.com)|OS Therapies Inc (OSTX) - Market Value|Radiopharm Theranostics - Market Value|ARTV (Artiva Biotherapeutics Inc.) - Market Capitalization|Market Capitalization Adlai Nortye Ltd.|Market Valuation VERU (Veru)|Market Value TPST|Market Value Xilio XLO|Renovaro Inc. (RENB) - Market Value|MURA - Market Value|Market Capitalization Kairos Pharma KAPA|OKUR (OnKure Therapeutics) - Market Valuation|Market Value CytoMed (GDTC)|Market Value Curis|Market Value APLM|Market Value tharimmune.com (THAR)|Market Valuation Advanced Biomed ADVB|Genprex, Inc - Market Valuation|Market Value CLDI|sunshinebiopharma.com - Market Capitalization|Market Value XBIO (xeneticbio.com)|SLRX (Salarius Pharmaceuticals) - Market Valuation|PPBT - Market Capitalization|Market Value American Oncology Network Inc|BGNE (BeiGene) - Market Value|Market Valuation CKPT (Checkpoint Therapeutics, Inc)|ELEV - Market Value|Market Capitalization ICAD (iCAD Inc.)|Ikena (IKNA) - Market Value|NTBL: Market Valuation|VIRX - Market Capitalization|MorphoSys Corp (MOR) - Market Value|Market Valuation NAYA Bio|Market Value Ascentage Pharma Group